BIOMAT Database Logo BIOMAT Database Logo

A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. 2010

Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy. strigari@ifo.it

OBJECTIVE To investigate the predictors of incidence and duration of xerostomia (XT) based on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole organ (TG) in head-and-neck cancer patients treated with intensity-modulated radiotherapy. METHODS A prospective study was initiated in May 2003. Sixty-three head-and-neck patients (44 with nasopharynx cancer) were included in the analysis. Using the dose-volume histogram the PG, SMG, and TG mean doses were calculated. Unstimulated and stimulated salivary flow were measured and XT-related questionnaires were compiled before and at 3, 6, 12, 18, and 24 months after radiotherapy. Salivary gland toxicity was evaluated using the Radiation Therapy Oncology Group scale, and Grade >or=3 toxicity was used as the endpoint. The XT incidence was investigated according to descriptive statistics and univariate and multivariate analysis. The Bonferroni method was used for multiple comparison adjustment. RESULTS After a reduced flow at 3 months after radiotherapy, recovery of salivary flow was observed over time. Primary site and salivary gland mean doses and volumes were identified in univariate analysis as prognostic factors. Multivariate analysis confirmed that TG mean dose (p = 0.00066) and pretreatment stimulated salivary flow (p = 0.00420) are independent factors for predicting XT. CONCLUSIONS The TG mean dose correlates with XT as assessed by Radiation Therapy Oncology Group criteria, salivary output, and XT-related questionnaires. Our results suggest that TG mean dose is a candidate dose constraint for reducing XT, requiring considerably more validation in non-nasopharyngeal cancer patients.

UI MeSH Term Description Entries
D008297 Male Males
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D010306 Parotid Gland The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR. Gland, Parotid,Glands, Parotid,Parotid Glands
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
September 2020, Head & neck,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
[Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].
October 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
August 2006, Clinical oncology (Royal College of Radiologists (Great Britain)),
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Incidence of xerostomia in locally advanced head-and-neck cancers in elderly patients treated with intensity-modulated radiotherapy.
January 2022, Journal of cancer research and therapeutics,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
November 2018, Head & neck,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
October 2006, International journal of radiation oncology, biology, physics,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
[Intensity modulated radiotherapy for head and neck cancer, dose constraint for normal tissue: Cochlea vestibular apparatus and brainstem].
October 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
[Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
October 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer.
November 2021, Scientific reports,
Lidia Strigari, and Marcello Benassi, and Giorgio Arcangeli, and Vicente Bruzzaniti, and Giuseppe Giovinazzo, and Laura Marucci
Intensity-modulated radiotherapy for head and neck cancer.
June 2007, Clinical advances in hematology & oncology : H&O,
Copied contents to your clipboard!